Results 121 to 130 of about 209,319 (317)
The Correlation between Leadership and Organizational Culture, and Influence on Employee's Job Attitude in Hotel Industry [PDF]
, 2010 Jae-Hyoung Lee
openalex +1 more source
Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation
Molecular Oncology, EarlyView.Cyclin D1 overexpression altered the cell adhesion pathway, while cyclin D2 upregulation had less impact on pathway enrichment analysis. Multiple myeloma (MM) patients with cyclin D1 overexpression showed reduced CD56 expression and increased circulating tumor cells (CTC) levels, suggesting that cyclin D1 may contribute to MM cell dissemination ...
Ignacio J. Cardona‐Benavides +13 more
wiley +1 more source
Scientific ReportsThis paper aims to propose a prediction method based on Deep Learning (DL) and Internet of Things (IoT) technology, focusing on the ecological security and tourist satisfaction of Ice-and-Snow Tourism (IST) to solve practical problems in this field ...
Baiju Zhang
doaj +1 more source
Predicting change in management accounting systems: national culture and industry effects
, 2001 John Joseph Williams, Alfred E. Seaman
openalex +2 more sources
Philippe Bouquillion, Jacob T. Matthews, Le Web collaboratif. Mutations des industries de la culture et de la communication [PDF]
, 2011 Gilles Bœnisch
openalex +1 more source
β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Molecular Oncology, EarlyView.Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero +8 more
wiley +1 more source
Contingent Valuation of Fostering Storytelling for Culture and Tourism Industry [PDF]
, 2011 Min‐Jae Lee, Ju-Yeon Kim, Kim Chul-Min
openalex +1 more source
Molecular Oncology, EarlyView.Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh +5 more
wiley +1 more source
Molecular Oncology, EarlyView.RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha +10 more
wiley +1 more source